Showing results (71-80 of 174) with videos related to

Sort By:
Pageof 18
Breast Cancer Research and Treatment|August 21, 2002
Evaluation of HER-2/NEU protein expression in breast cancer by immunohistochemistry: an interlaboratory study assessing the reproducibility of HER-2/NEU testingDavid Gancberg, Tero Järvinen, Angelo di Leo, et al.
Biomolecules|December 18, 2020
Cell-Free DNA-Methylation-Based Methods and Applications in OncologyFrancesca Galardi, Francesca De Luca, Dario Romagnoli, et al.
International Journal of Clinical Oncology|August 31, 2002
Predictive molecular markers in the adjuvant therapy of breast cancer: state of the art in the year 2002Angelo Di Leo, Fatima Cardoso, Virginie Durbecq, et al.
Oncotarget|September 17, 2016
A gene expression signature of retinoblastoma loss-of-function is a predictive biomarker of resistance to palbociclib in breast cancer cell lines and is prognostic in patients with ER positive early breast cancerLuca Malorni, Silvano Piazza, Yari Ciani, et al.
NPJ Breast Cancer|February 13, 2021
Meta-analyses of visceral versus non-visceral metastatic hormone receptor-positive breast cancer treated by endocrine monotherapiesJohn F R Robertson, Angelo Di Leo, Stephen Johnston, et al.
Clinical Breast Cancer|December 9, 2004
Potential predictive value of Bcl-2 for response to tamoxifen in the adjuvant setting of node-positive breast cancerFatima Cardoso, Marianne Paesmans, Denis Larsimont, et al.
Plos One|May 14, 2013
The efficacy of lapatinib in metastatic breast cancer with HER2 non-amplified primary tumors and EGFR positive circulating tumor cells: a proof-of-concept studyJustin Stebbing, Rachel Payne, Justine Reise, et al.
Sao Paulo Medical Journal = Revista Paulista De Medicina|February 27, 2007
Extensive deep vein thrombosis as a complication of testicular cancer treated with the BEP protocol (bleomycin, etoposide and cisplatin): case reportMax Senna Mano, José Luiz Miranda Guimarães, Sören Franz Marian Chicata Sutmöller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2010
Chromosome 17 polysomy without human epidermal growth factor receptor 2 amplification does not predict response to lapatinib plus paclitaxel compared with paclitaxel in metastatic breast cancerLeona Downey, Robert B Livingston, Maria Koehler, et al.
Anticancer Research|August 15, 2002
HER-2/neu evaluation by immunohistochemistry and fluorescence in situ hybridization in breast cancer: implications for daily laboratory practiceDenis Larsimont, Angelo Di Leo, Ghizlane Rouas, et al.
Pageof 18